TSXV:TRL.H - Post by User
Comment by
eSnowdenon Nov 11, 2014 6:45am
![](https://assets.stockhouse.com/kentico-cms/0340-00/images/Sprite.svg#id_Post_Views_Icon)
308 Views
Post# 23116316
RE:RE:RE:RBC
RE:RE:RE:RBCHere's the magical thing...TRL management is wasting time/resources on Estrace--a drug that will bring in 5-6mm a year, when they have a drug (natesto) that could easily do that number in a qtr--yet they can't seem to get the ball rolling.
How about get the thing launched without a partner--Medicure doesn't rely on a partner for their drug; they contract out the sales force. Why can't Trimel do the same. This company is full of excuses and the share price reflects this.